Kudzu root Pueraria montana var. lobata (Willd.) Maesen & S.M.Almeida ex Sanjappa & Predeep
Also called: kudzu, Pueraria lobata (synonym), Pueraria thunbergiana (synonym), Radix puerariae
Kudzu is a legume whose root is used in traditional Chinese medicine. Root extracts rich in isoflavones, mainly puerarin, have been studied for reducing alcohol intake. Pueraria mirifica is a separate species.
- Category
- Botanical
- Part used
- Root (extracts standardized to isoflavones); flowers also used traditionally
- Strongest evidence
- C Limited
- Native range
- Native from China to northern Australia (POWO: "China to N. Australia")
- Reviewed
- 2026-10-29
Class 2 Moderately studied in people. This entry cites 3 RCTs of kudzu root extract alone (sources [3], [5], [6]), 17 to 20 participants. Two further placebo-controlled crossover studies (sources [4], [7]) do not state that the kudzu-placebo order was randomized. [3]
Fact-checked 2026-10-29 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Alcohol intake in non-treatment-seeking heavy drinkers | C | In a 4-week RCT of 17 young men, extract (250 mg isoflavones three times daily) cut weekly drinks by 34-57% and raised abstinent days, without affecting craving. [3] |
| Beer intake by heavy drinkers in a naturalistic laboratory | C | In a placebo-controlled crossover study, 7 days of kudzu extract reduced the number of beers consumed, slowed drinking, and did not change the urge to drink; no side effects were reported. [4] |
| Single dose before a binge-drinking session | C | In 20 men (10 per group), one dose (2 g, 520 mg isoflavones) given 2.5 hours before a session reduced beers from 3.0 to 1.9, while the placebo group rose from 2.7 to 3.4. [5] |
| Alcohol use disorder in people receiving counseling | C | In an 8-week double-blind trial in 19 treatment-seeking men and women, extract (750 mg isoflavones daily) did not reduce heavy drinking more than placebo (30% vs 44% reduction). [6] |
Main constituents: Puerarin, the major isoflavone in a kudzu (Pueraria lobata) extract [1]; Isoflavones are the major components; tectorigenin is another isoflavone studied in the lab [2]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Studied in a trial: extract providing 250 mg isoflavones three times daily for 4 weeks. [3]
- Studied in a trial: extract providing 750 mg isoflavones daily for 8 weeks. [6]
- Studied: a single 2 g dose of extract with 520 mg isoflavones. [5]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicines4 listed
Tamoxifen; Methotrexate; Antidiabetic drugs; CYP2D6 and CYP1A2 substrates
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notificationsNone on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- In a 4-week trial in 17 men, there were no adverse events and no changes in vital signs, blood chemistry, or kidney or liver function. [3]
- Case reports: acute interstitial nephritis after 10 days of kudzu root juice; liver injury after mistletoe and kudzu extracts (cause uncertain). [2]
- Because human and animal studies suggest estrogenic effects, MSK advises that people with hormone-sensitive cancers or taking tamoxifen should avoid kudzu. [2]
Interactions
| With | What happens |
|---|---|
| Tamoxifen | Kudzu has some estrogenic activity and may antagonize tamoxifen; clinical relevance has yet to be determined. [2] |
| Methotrexate | In animal models, a kudzu root decoction reduced methotrexate elimination, raising its levels. [2] |
| Drugs metabolized by CYP2D6 or CYP1A2 | In vitro, puerarin inhibited CYP2D6 and induced CYP1A2; clinical relevance has yet to be determined. [2] |
| Alcohol | In 12 moderate drinkers, 9 days of extract did not change subjective or psychomotor effects of alcohol; plasma ethanol rose slightly faster for 10-15 minutes at the higher alcohol dose, with no change in peak levels. [7] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
Regulatory status
- US: FDA states that under DSHEA it does not have the authority to approve dietary supplements before they are marketed; firms are responsible for safety and labeling, and an NDI notification is required for certain new dietary ingredients. [9]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- No NDI notification naming kudzu (Pueraria montana var. lobata / Pueraria lobata) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. NDIs 174, 244 and 268 name Pueraria mirifica, a different plant. [P3]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- Tamoxifen: Estrogenic activity may antagonize tamoxifen; clinical relevance not determined. [P2]
- Methotrexate: Root decoction reduced methotrexate elimination in animals. [P2]
- Antidiabetic drugs: Puerarin had antihyperglycemic effects in animal models; clinical relevance not determined. [P2]
- CYP2D6 and CYP1A2 substrates: In vitro, puerarin inhibited CYP2D6 and induced CYP1A2; clinical relevance not determined. [P2]
Alcohol
- Penetar et al. 2011 (12 moderate drinkers, 750 mg/day isoflavones for 9 days): no change in subjective or psychomotor alcohol effects; slightly faster early rise in plasma ethanol at 0.7 g/kg for 10-15 minutes, same peak; heart rate and skin temperature effects of alcohol were enhanced. [P6]
Interactions with other herbs and supplements
- Mistletoe: Case report of liver injury after mistletoe and kudzu extracts; uncertain whether either, both, or an interaction caused it. [P2]
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of each component that is a dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under (a)(1)(ii). [P7]
- Species identity distinguishing Pueraria montana var. lobata from other Pueraria (e.g., P. mirifica) — Sources group several Pueraria species, including P. mirifica, under kudzu; P. mirifica is a separate accepted species. [P2]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- Puerarin from a kudzu extract was rapidly absorbed orally, peaked at about 2 hours, and had a half-life of about 4.3 hours, unchanged after repeated dosing. [P1]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- Penetar DM, et al. Pharmacokinetic profile of the isoflavone puerarin after acute and repeated administration of a novel kudzu extract to human volunteers. J Altern Complement Med 2006;12(6):543-8 (PMID 16884345), 2006-07. pubmed.ncbi.nlm.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Kudzu (last updated February 4, 2022), 2022-02-04. mskcc.org
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (1,060 agents, Volumes 1-142; checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports series list (607 reports; checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- Penetar DM, et al. Kudzu extract treatment does not increase the intoxicating effects of acute alcohol in human volunteers. Alcohol Clin Exp Res 2011;35(4):726-34 (PMID 21244439), 2011-04. pubmed.ncbi.nlm.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
Sources
- Penetar DM, et al. Pharmacokinetic profile of the isoflavone puerarin after acute and repeated administration of a novel kudzu extract to human volunteers. J Altern Complement Med 2006;12(6):543-8 (PMID 16884345), 2006-07. pubmed.ncbi.nlm.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Kudzu (last updated February 4, 2022), 2022-02-04. mskcc.org
- Lukas SE, et al. A standardized kudzu extract (NPI-031) reduces alcohol consumption in nontreatment-seeking male heavy drinkers. Psychopharmacology (Berl) 2013;226(1):65-73 (PMID 23070022), 2013-03. pubmed.ncbi.nlm.nih.gov
- Lukas SE, et al. An extract of the Chinese herbal root kudzu reduces alcohol drinking by heavy drinkers in a naturalistic setting. Alcohol Clin Exp Res 2005;29(5):756-62 (PMID 15897719), 2005-05. pubmed.ncbi.nlm.nih.gov
- Penetar DM, et al. A single dose of kudzu extract reduces alcohol consumption in a binge drinking paradigm. Drug Alcohol Depend 2015;153:194-200 (PMID 26048637), 2015-08-01. pubmed.ncbi.nlm.nih.gov
- Keith DR, et al. Effects of kudzu extract on alcohol consumption among men and women seeking treatment for alcohol use disorder. Drug Alcohol Depend Rep 2026;21:100473 (PMID 42779941), 2026-09-04. pubmed.ncbi.nlm.nih.gov
- Penetar DM, et al. Kudzu extract treatment does not increase the intoxicating effects of acute alcohol in human volunteers. Alcohol Clin Exp Res 2011;35(4):726-34 (PMID 21244439), 2011-04. pubmed.ncbi.nlm.nih.gov
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew. Pueraria mirifica Airy Shaw & Suvat.: accepted name and native range as recorded in WCVP, the taxonomic index of POWO (WCVP Darwin Core archive, GBIF dataset f382f0ce-323a-4091-bb9f-add557f3a9a2, published 2026-06-04; read 2026-10-29), 2026-06-04. powo.science.kew.org
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew. Pueraria montana var. lobata (Willd.) Maesen & S.M.Almeida ex Sanjappa & Predeep: accepted name and native range as recorded in WCVP, the taxonomic index of POWO (WCVP Darwin Core archive, GBIF dataset f382f0ce-323a-4091-bb9f-add557f3a9a2, published 2026-06-04; read 2026-10-29), 2026-06-04. powo.science.kew.org
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.